SK bioscience Co.,Ltd.
302440.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
201
Cost of Revenue
177
Gross Profit
23
Gross Margin
11.6%
Operating Income
-104
Operating Margin
-51.7%
Net Income
-40
Net Margin
-20.1%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-27
EBITDA Margin
-13.5%
2023
12/31/2023
Revenue
277
Cost of Revenue
171
Gross Profit
106
Gross Margin
38.4%
Operating Income
-4
Operating Margin
-1.3%
Net Income
17
Net Margin
6.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
33
EBITDA Margin
11.8%
2022
12/31/2022
Revenue
343
Cost of Revenue
163
Gross Profit
180
Gross Margin
52.5%
Operating Income
86
Operating Margin
25.2%
Net Income
92
Net Margin
26.8%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
129
EBITDA Margin
37.5%
2021
12/31/2021
Revenue
697
Cost of Revenue
269
Gross Profit
428
Gross Margin
61.4%
Operating Income
356
Operating Margin
51.0%
Net Income
266
Net Margin
38.2%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
370
EBITDA Margin
53.1%
2020
12/31/2020
Revenue
169
Cost of Revenue
98
Gross Profit
72
Gross Margin
42.3%
Operating Income
28
Operating Margin
16.7%
Net Income
25
Net Margin
14.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
43
EBITDA Margin
25.7%